- |||||||||| Paxlovid (nirmatrelvir and ritonavir) / Pfizer, Lagevrio (molnupiravir) / Ridgeback Biotherap, Merck (MSD)
Review, Journal: Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19. (Pubmed Central) - Jan 26, 2022 These examples highlight the importance of structure in drug discovery to combat COVID-19. We also discussed the recent variants of Omicron and its implication in immunity escape from existing vaccines and antibody therapies.
- |||||||||| Paxlovid (nirmatrelvir and ritonavir) / Pfizer, Xevudy (sotrovimab) / GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
Clinical: But UW is using NIH “strict eligibility criteria” & prioritizing UNvaccinated folks for post-infection Covid treatment (not Evushield). In WA, unless you’re severely immunocompromised, e.g., organ transplant, if you’re vaxxed, realistically, you can’t get Paxlovid or Sotrovimab. (Twitter) - Jan 26, 2022
- |||||||||| Paxlovid (nirmatrelvir and ritonavir) / Pfizer
Paxlovid needed imo (Twitter) - Jan 24, 2022
- |||||||||| fluvoxamine / Generic mfg., Paxlovid (nirmatrelvir and ritonavir) / Pfizer
Clinical: I'm discussing “🦠COVID-19💊Drug-Drug💊Interactions🦠: Fluvoxamine, Paxlovid…” with @AngelaReiersen, Dr Alice Duncan, @RayTaylorUK, Eleazar San Agustin, Vipul Shah, @hypomaniac07, and World Mental Health. Today, 22 Jan at 11:00 PM GMT 7 in @clubhouse. Join us! (Twitter) - Jan 23, 2022
|